Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Imatinib> ?p ?o }
- Imatinib abstract "Imatinib (INN), marketed by Novartis as Gleevec (Canada, South Africa and the USA) or Glivec (Australia, Europe and Latin America), and sometimes referred to by its investigational name STI-571, is a tyrosine-kinase inhibitor used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML).In order to survive, cells need signaling through proteins (signal cascade) to keep them alive. Some of the proteins in this cascade use a phosphate group as an \"on\" switch. This phosphate group is added by a tyrosine kinase enzyme. In healthy cells, these tyrosine kinase enzymes are turned on and off as needed. In Ph-positive CML cells, one tyrosine kinase enzyme, BCR-Abl, is stuck on the \"on\" position, and keeps adding phosphate groups. Imatinib blocks this BCR-Abl enzyme, and stops it from adding phosphate groups. As a result, these cells stop growing, and even die by a process of cell death (apoptosis). Because the BCR-Abl tyrosine kinase enzyme exists only in cancer cells and not in healthy cells, imatinib works as a form of targeted therapy—only cancer cells are killed through the drug's action. In this regard, imatinib was one of the first cancer therapies to show the potential for such targeted action, and is often cited as a paradigm for research in cancer therapeutics.Due in large part to the development of Gleevec and related drugs having a similar mechanism of action, the five year survival rate for people with chronic myeloid leukemia nearly doubled from 31% in 1993 (before Gleevec's 2001 FDA approval) to 59% for those diagnosed between 2003 and 2009. Compared to older drugs imatinib has a relatively benign side effect profile, allowing many patients to live a normal lifestyle. Median survival for imatinib-treated people with gastrointestinal stromal tumors (GIST) is nearly 5 years compared to 9 to 20 months in the pre-imatinib-era.Physicians have commented that the cost of imatinib is excessive. In the USA, the patent protecting the active principle expired on 4 January 2015 while the patent protecting the beta crystal form of the active principal ingredient will expire on 23 May 2019. In India, the patent was rejected, in an Indian Supreme Court decision in 2013.It is on the World Health Organization's List of Essential Medicines, a list of the medications needed to cover the majority of health care needs in a health system. The developers of imatinib were awarded the Lasker Award in 2009 and the Japan Prize in 2012. Gleevec is the beta crystalline form of imatinib mesilate, the mesylate salt of imatinib.".
- Imatinib atcPrefix "L01".
- Imatinib atcSuffix "XE01".
- Imatinib bioavailability "98.0".
- Imatinib casNumber "152459-95-5".
- Imatinib casSupplemental "(mesilate)".
- Imatinib chEBI "45783".
- Imatinib drugbank "DB00619".
- Imatinib fdaUniiCode "BKJ8M8G5HI".
- Imatinib iupacName "4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide".
- Imatinib pubchem "5291".
- Imatinib thumbnail Imatinib2DACS.svg?width=300.
- Imatinib wikiPageExternalLink imatinibmesylate.
- Imatinib wikiPageExternalLink ?ligand=STI.
- Imatinib wikiPageID "561843".
- Imatinib wikiPageLength "47515".
- Imatinib wikiPageOutDegree "182".
- Imatinib wikiPageRevisionID "702321923".
- Imatinib wikiPageWikiLink ABL_(gene).
- Imatinib wikiPageWikiLink Active_ingredient.
- Imatinib wikiPageWikiLink Active_site.
- Imatinib wikiPageWikiLink Acute_lymphoblastic_leukemia.
- Imatinib wikiPageWikiLink Adenosine_triphosphate.
- Imatinib wikiPageWikiLink Aggressive_fibromatosis.
- Imatinib wikiPageWikiLink PKB_signaling_pathway.
- Imatinib wikiPageWikiLink Alzheimers_disease.
- Imatinib wikiPageWikiLink Amine.
- Imatinib wikiPageWikiLink Amyloid_beta.
- Imatinib wikiPageWikiLink Anemia.
- Imatinib wikiPageWikiLink Apoptosis.
- Imatinib wikiPageWikiLink Approved_Drug_Products_with_Therapeutic_Equivalence_Evaluations.
- Imatinib wikiPageWikiLink Atherosclerosis.
- Imatinib wikiPageWikiLink Attenuated_vaccine.
- Imatinib wikiPageWikiLink Bcl-2.
- Imatinib wikiPageWikiLink Bcr-Abl_tyrosine-kinase_inhibitor.
- Imatinib wikiPageWikiLink Benzamide.
- Imatinib wikiPageWikiLink Binding_site.
- Imatinib wikiPageWikiLink Bioavailability.
- Imatinib wikiPageWikiLink Blood–brain_barrier.
- Imatinib wikiPageWikiLink Brian_Druker.
- Imatinib wikiPageWikiLink C-terminus.
- Imatinib wikiPageWikiLink CD117.
- Imatinib wikiPageWikiLink CYP1A2.
- Imatinib wikiPageWikiLink CYP2C19.
- Imatinib wikiPageWikiLink CYP2C9.
- Imatinib wikiPageWikiLink CYP2D6.
- Imatinib wikiPageWikiLink CYP3A4.
- Imatinib wikiPageWikiLink Cancer_cell.
- Imatinib wikiPageWikiLink Captisol.
- Imatinib wikiPageWikiLink Cardiac_muscle.
- Imatinib wikiPageWikiLink Carlo_Gambacorti-Passerini.
- Imatinib wikiPageWikiLink Catalysis.
- Imatinib wikiPageWikiLink Category:Benzanilides.
- Imatinib wikiPageWikiLink Category:Non-receptor_tyrosine_kinase_inhibitors.
- Imatinib wikiPageWikiLink Category:Piperazines.
- Imatinib wikiPageWikiLink Category:Pyridines.
- Imatinib wikiPageWikiLink Category:Pyrimidines.
- Imatinib wikiPageWikiLink Category:World_Health_Organization_essential_medicines.
- Imatinib wikiPageWikiLink Charles_Sawyers.
- Imatinib wikiPageWikiLink Chloramphenicol.
- Imatinib wikiPageWikiLink Chronic_eosinophilic_leukemia.
- Imatinib wikiPageWikiLink Chronic_myelogenous_leukemia.
- Imatinib wikiPageWikiLink Ciclosporin.
- Imatinib wikiPageWikiLink Clarithromycin.
- Imatinib wikiPageWikiLink Counterion.
- Imatinib wikiPageWikiLink Cyclodextrin.
- Imatinib wikiPageWikiLink Cytochrome_P450.
- Imatinib wikiPageWikiLink Dermatofibrosarcoma_protuberans.
- Imatinib wikiPageWikiLink Diabetes_mellitus.
- Imatinib wikiPageWikiLink Drug_design.
- Imatinib wikiPageWikiLink Edema.
- Imatinib wikiPageWikiLink Enzyme_inhibitor.
- Imatinib wikiPageWikiLink European_Patent_Office.
- Imatinib wikiPageWikiLink Food_and_Drug_Administration.
- Imatinib wikiPageWikiLink Gamma_secretase.
- Imatinib wikiPageWikiLink Gastrointestinal_stromal_tumor.
- Imatinib wikiPageWikiLink Grapefruit_juice.
- Imatinib wikiPageWikiLink Half-life.
- Imatinib wikiPageWikiLink Hammersmith_Hospital.
- Imatinib wikiPageWikiLink Heart_failure.
- Imatinib wikiPageWikiLink High-throughput_screening.
- Imatinib wikiPageWikiLink History_of_cancer_chemotherapy.
- Imatinib wikiPageWikiLink Hypereosinophilic_syndrome.
- Imatinib wikiPageWikiLink Hypericum_perforatum.
- Imatinib wikiPageWikiLink In_vitro.
- Imatinib wikiPageWikiLink Inactivated_vaccine.
- Imatinib wikiPageWikiLink Insulin_receptor.
- Imatinib wikiPageWikiLink International_nonproprietary_name.
- Imatinib wikiPageWikiLink Isozyme.
- Imatinib wikiPageWikiLink Itraconazole.
- Imatinib wikiPageWikiLink JAK-STAT_signaling_pathway.
- Imatinib wikiPageWikiLink Japan_Prize.
- Imatinib wikiPageWikiLink Ketoconazole.
- Imatinib wikiPageWikiLink Kidney.
- Imatinib wikiPageWikiLink Lasker-DeBakey_Clinical_Medical_Research_Award.
- Imatinib wikiPageWikiLink Lasker_Award.
- Imatinib wikiPageWikiLink Lead_compound.
- Imatinib wikiPageWikiLink Levothyroxine.
- Imatinib wikiPageWikiLink Liver.
- Imatinib wikiPageWikiLink Malignancy.